Latest Expert Opinions

Signal
Opinion
Expert
BUY WEAKNESS
BUY WEAKNESS
November 7, 2018
Trading at 32x earnings with a 20% growth rate. The 200-day is trending higher. A really nice trend. A solid stock. $82.50-83.00 is where he'd buy.
Trading at 32x earnings with a 20% growth rate. The 200-day is trending higher. A really nice trend. A solid stock. $82.50-83.00 is where he'd buy.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$88.230
Owned
No
DON'T BUY
DON'T BUY
November 7, 2018
Owns Alibaba instead. JD is like Amazon for China. Its market cap is larger than eBay's. There's so much negative sentiment around Chinese internet stocks now, so they've come down. Trading at 58x forward earnings--pricey, but long-term growth is estimated at 50%+. Possible take-out from another company. Need to see a basing pattern first before buying this. Also, there are allegations of misconduct about the CEO/founder.
JD.com Inc(JD-Q)
November 7, 2018
Owns Alibaba instead. JD is like Amazon for China. Its market cap is larger than eBay's. There's so much negative sentiment around Chinese internet stocks now, so they've come down. Trading at 58x forward earnings--pricey, but long-term growth is estimated at 50%+. Possible take-out from another company. Need to see a basing pattern first before buying this. Also, there are allegations of misconduct about the CEO/founder.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$24.070
Owned
No
BUY
BUY
November 7, 2018
Just reported earnings last week, beating the street by 6%. It's been sideways, but pays a 4.9% dividend that should grow. Trades at 10x forward earnings at a 11% growth rate. But the market isn't recognizing this now. It's a good healthcare name, and healthcare has been outperforming the S&P in the current late cycle. ABBV has beaten earnings many quarters in a row.
AbbVie Inc.(ABBV-N)
November 7, 2018
Just reported earnings last week, beating the street by 6%. It's been sideways, but pays a 4.9% dividend that should grow. Trades at 10x forward earnings at a 11% growth rate. But the market isn't recognizing this now. It's a good healthcare name, and healthcare has been outperforming the S&P in the current late cycle. ABBV has beaten earnings many quarters in a row.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$86.960
Owned
Yes
DON'T BUY
DON'T BUY
November 7, 2018
The effect of the Democrats winning the House in the US Midterms? Both parties are still committed to defence spending, he's read. Below its 200-day moving average. Trading at 16x earnings with a 14% growth rate. It does not scream buy. Look at other names like Boeing. He doesn't own any defence names. Also, industrials tend to underperform in late cycles.
Raytheon(RTN-N)
November 7, 2018
The effect of the Democrats winning the House in the US Midterms? Both parties are still committed to defence spending, he's read. Below its 200-day moving average. Trading at 16x earnings with a 14% growth rate. It does not scream buy. Look at other names like Boeing. He doesn't own any defence names. Also, industrials tend to underperform in late cycles.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$187.320
Owned
No
DON'T BUY
DON'T BUY
November 7, 2018
Telecoms are high-dividend payers. Great income, but this has been falling, trending below its 200-day moving average. Great cash flow. There's more room for wireless penetration in Canada than the US. But rising interest rates will pressure telecom stocks. Better to wait until rates settle in 12-18 months. Better to look for dividend growers than high-dividend payers.
BCE Inc.(BCE-T)
November 7, 2018
Telecoms are high-dividend payers. Great income, but this has been falling, trending below its 200-day moving average. Great cash flow. There's more room for wireless penetration in Canada than the US. But rising interest rates will pressure telecom stocks. Better to wait until rates settle in 12-18 months. Better to look for dividend growers than high-dividend payers.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$53.590
Owned
Unknown
DON'T BUY
DON'T BUY
November 7, 2018
Owns SunLife instead. Interest rates are rising and pressuring these stocks. He likes MFC's exposure to Asia, which will help them long term. But MFC has been sideways. He needs to see MFC to rise far above its 200-day moving average before stepping in. Pays a 4.7% dividend, but little dividend growth.
Manulife Financial(MFC-T)
November 7, 2018
Owns SunLife instead. Interest rates are rising and pressuring these stocks. He likes MFC's exposure to Asia, which will help them long term. But MFC has been sideways. He needs to see MFC to rise far above its 200-day moving average before stepping in. Pays a 4.7% dividend, but little dividend growth.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$21.440
Owned
No
DON'T BUY
DON'T BUY
November 7, 2018
He likes the tech space which has runway to grow. It holds Apple, but it doesn't own FB anymore, but it owns Visa and Mastercard. He'd rather buy the individual names than the ETF. That said, don't overweight this space--people have been piling in and the trade is getting crowded. As for Apple, guidance for phone sales forward will be weaker, so that's a caveat. Depends on 60% of revenues on the iPhone, too.
He likes the tech space which has runway to grow. It holds Apple, but it doesn't own FB anymore, but it owns Visa and Mastercard. He'd rather buy the individual names than the ETF. That said, don't overweight this space--people have been piling in and the trade is getting crowded. As for Apple, guidance for phone sales forward will be weaker, so that's a caveat. Depends on 60% of revenues on the iPhone, too.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$190.500
Owned
No